Aurobindo Pharma’s US arm is voluntarily recalling a lot of Gabapentin capsules as the product lot has been found to contain some empty capsules. Gabapentin is used as in the treatment of epilepsy and for the management of postherpetic neuralgia (pain after shingles). Aurobindo Pharma, however, had not received any reports of adverse events related to this recall to date, but has received four complaints for empty capsules. Aurobindo’s scrip was down 0.71 per cent on the BSE on Tuesday to close at ₹1110.45.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.